PT-141 10mg

PT-141

Melanocortin Receptor Agonist Peptide

PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide and analog of alpha-melanocyte-stimulating hormone (α-MSH). It is widely studied in scientific literature for its role in cellular processes related to melanocortin receptor signaling and neuropeptide interaction.

Within research environments, PT-141 is frequently referenced in studies exploring melanocortin receptor activity, particularly at the MC3R and MC4R subtypes, and central nervous system signaling pathways. Its structure allows for targeted investigation into biological systems associated with neuropeptide-mediated response, central signaling cascades, and receptor-specific binding profiles.

Ongoing laboratory and academic research continues to examine PT-141's broader role in melanocortin pathways, receptor interaction, and biochemical activity. Its cyclic peptide structure makes it a consistent focus in advanced neuropeptide and receptor signaling research.

Research Focus Areas

• Melanocortin receptor (MC3R/MC4R) signaling
• Central nervous system peptide pathways
• Neuropeptide receptor binding studies
• Cyclic peptide structural research

Notice: This material is intended for educational and research use only by qualified professionals. It is not approved by the U.S. Food and Drug Administration (FDA) for the diagnosis, treatment, or prevention of any disease. No clinical use guidance is provided.